Nuveen Asset Management, LLC Gt Biopharma, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.11 $116,223 - $220,399	-70,868 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.6 - $3.3 $2,134 - $2,709	821 Added 1.17%	70,868 $204,000
Q4 2021 Feb 14, 2022	SELL	$3.05 - $7.08 $26,583 - $61,709	-8,716 Reduced 11.07%	70,047 $213,000
Q3 2021 Nov 12, 2021	SELL	$6.68 - $15.26 $22,631 - $51,700	-3,388 Reduced 4.12%	78,763 $613,000
Q2 2021 Aug 16, 2021	BUY	$7.19 - $18.96 $590,665 - $1.56 Million	82,151 New	82,151 $1.27 Million

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $81.7M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.